Sunday, 16 Dec 2018

Bangla Version

Breast cancer survival unaffected by faulty gene

No icon Spot Light

Health Desk: 12 January, 2018— Young breast cancer patients with faulty BRCA genes have the same survival chances as those without, a study has found.

The researchers, who looked at almost 3,000 women, also found outcomes were the same whatever kind of treatment women had - including mastectomies.

Experts say it means women can be take time to decide if the radical surgery is right for them.

The study did not look at preventative mastectomies.

These are offered to women with faulty genes to cut their risk of developing cancer.

But the study did not look at preventative mastectomies - where women with a faulty BRCA gene opt for the surgery to reduce their risk of going on to develop cancer,

The BRCA1 and BRCA2 gene mutations increase a woman's risk of breast cancer by four-to-eightfold.

It has been dubbed the 'Angelina Jolie gene', after the actress revealed she underwent preventative surgery on learning she had an up to 87% chance of developing breast cancer.

The study found 12% of 2,733 women aged 18 to 40 treated for breast cancer at 127 hospitals across the UK between 2000 and 2008 had a BRCA mutation.

The study published in The Lancet Oncology. 

Courtesy: BBC Health